CytomX Therapeutics (CTMX) Receivables (2014 - 2026)
CytomX Therapeutics' Receivables was $37.49 million in Q2 2026, compared with $1.87 million a year earlier.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Receivables (2014 - 2026) Analysis & Trends
At the end of FY2025, Receivables at CytomX Therapeutics came in at $2.01 million, down 35.1% from FY2024.
- Receivables has now declined for three consecutive years, though with a five-year compound annual growth rate of 20.3% (FY2020 to FY2025).
- In earlier years, Receivables was $3.1 million in FY2024 (-9.6%), $3.43 million in FY2023 (-90.5%), $35.99 million in FY2022 and $790,000 in FY2021 (-1.0%).
- The Q2 2026 figure marks the highest quarterly Receivables since Q1 2020.
- Compared with a year earlier, Receivables was higher in 1 of the last seven quarters, with an average decline of 34.6%.
- The best year-over-year quarter for Receivables over five years was Q3 2022 (growth of 93.0%); the worst was Q4 2023 (a decline of 90.5%).
- Per Business Quant data, CTMX's Receivables in the three quarters before Q2 2026 was $646,000 (Q1 2026), $2.01 million (Q4 2025) and $1.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | CytomX Therapeutics | 586.15 Mn | -371.52 Mn | - | 37.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.49 Mn |
| Mar 31, 2026 | 646,000.00 |
| Dec 31, 2025 | 2.01 Mn |
| Sep 30, 2025 | 1.63 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 1.96 Mn |
| Dec 31, 2024 | 3.10 Mn |
| Sep 30, 2024 | 3.35 Mn |
| Jun 30, 2024 | 2.78 Mn |
| Mar 31, 2024 | 13.18 Mn |
| Dec 31, 2023 | 3.43 Mn |
| Sep 30, 2023 | 2.42 Mn |
| Jun 30, 2023 | 1.90 Mn |
| Mar 31, 2023 | 1.09 Mn |
| Dec 31, 2022 | 35.99 Mn |
| Sep 30, 2022 | 1.71 Mn |
| Jun 30, 2022 | 1.01 Mn |
| Mar 31, 2022 | 1.02 Mn |
| Dec 31, 2021 | 790,000.00 |
| Sep 30, 2021 | 887,000.00 |
API Access
CytomX Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();